[ 1] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 2] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 3] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 4] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 5] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 6] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 7] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 8] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 9] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 10] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 11] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 12] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 13] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 14] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 15] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 16] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 17] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 18] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 19] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 20] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 21] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 22] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 23] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 25] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 26] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 27] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 28] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 29] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 30] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 31] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 32] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 33] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 34] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 35] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 36] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 37] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 40] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 41] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 42] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 43] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 44] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 47] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 48] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 49] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 50] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 51] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 52] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 53] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 54] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 55] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 56] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 57] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 58] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 61] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 62] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 63] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 64] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 65] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 66] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 67] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 68] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 69] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 70] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 71] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 72] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 73] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 74] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 75] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 76] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 77] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 78] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 79] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 82] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 83] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 84] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 85] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 86] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 87] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 88] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 90] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 91] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 92] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 93] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [ 94] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [ 95] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 96] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 98] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [ 99] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [100] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [101] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [102] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [103] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [104] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [105] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [108] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [109] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [110] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [111] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [112] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [113] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [114] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [115] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [118] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [119] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [120] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [121] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [122] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [123] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [124] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [125] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [127] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [128] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [129] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [130] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [131] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [132] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [133] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [134] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [135] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [136] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [137] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [140] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [141] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [142] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [143] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [144] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [145] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [146] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [147] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [148] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [149] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [150] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [151] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [152] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [153] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [154] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [155] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [156] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [157] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [158] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [159] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [160] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [161] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [164] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [165] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [166] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [167] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [168] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [169] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [170] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [171] Press Release (2026-02-04)/Metropolis Healthcare Limited has informed the Exchange regarding a press release dated February 04, 2026, titled Metropolis Healthcare Sustains Strong Growth Momentum; Revenue Rises 26% YoY to ₹406 Crore; PAT Surges 63% . [172] Press Release (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.". [173] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [176] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [177] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [178] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [179] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [180] General Updates (2026-02-10)/Nephrocare Health Services Limited has informed the Exchange and attached herewith presentation being made to Investor/ Analyst on the financial results for the quarter and nine months ended 31st December, 2025. [181] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India . [182] Press Release (2026-04-01)/Gaudium IVF and Women Health Limited has informed the Exchange regarding a press release dated April 01, 2026, titled Gaudium IVF Introduces AI-Led Infertility Treatment, Marking an Industry First in India .